observed an increase in tryptophan metabolism among breast cancer patients compared to healthy controls, with significant differences in plasma tryptophan and kynurenine/tryptophan ratios in hormone receptor‐negative patients [31]. This evidence concerns the gene NR4A1 and breast carcinoma.